Skip to content

The safety and efficacy of hysteroscopic myomectomy for FIGO type 3 fibroids in infertile women: a prospective cohort study.

The safety and efficacy of hysteroscopic myomectomy for FIGO type 3 fibroids in infertile women: a prospective cohort study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114688
Enrollment
Unknown
Registered
2025-12-16
Start date
2025-12-16
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility and FIGO type 3 fibroids

Interventions

Resection group:None
Non-resection group:None

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Women diagnosed with infertility; 2.Transvaginal ultrasound showing FIGO type 3 fibroid(s) <=5 cm in maximal diameter, who subsequently underwent hysteroscopic myomectomy at our institution; 3.Complete clinical data sets available; 4.Strong desire for fertility and active attempt to conceive after surgery.

Exclusion criteria

Exclusion criteria: 1.Concurrent congenital reproductive-tract malformations (e.g., septate, unicornuate, bicornuate, or didelphic uterus); 2.Co-existing intrauterine adhesions or thin endometrium (defined as endometrial thickness <7 mm in the late follicular phase or on the day of endometrial transformation under hormone-replacement therapy); 3.Concomitant adenomyosis; 4.Any medical, surgical, or psychiatric disorder contraindicating pregnancy, including—but not limited to—uncontrolled malignant neoplasm, uncontrolled diabetes mellitus, New York Heart Association class III–IV cardiac insufficiency, cyanotic congenital heart disease, severe arrhythmia, thyrotoxic crisis, severe hypothyroidism, or acute exacerbation of schizophrenia.

Design outcomes

Primary

MeasureTime frame
Live birth rate;Clinical pregnancy rate;

Secondary

MeasureTime frame
Time to pregnancy;Ectopic pregnancy rate;Biochemical pregnancy rate;Ongoing pregnancy rate;Miscarriage rate;

Countries

China

Contacts

Public ContactWang Chao

Peking University Third Hospital

1210301414@pku.edu.cn+86 10 82266699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026